Paid Clinical Trials in Utah

Utah has 1,256 paid clinical trials enrolling now across cities including Salt Lake City, Murray and West Valley City. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 14, 2026.

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

1,106 clinical trials

Get a weekly email when new trials open in Salt Lake City, UT.

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

for Crohn's Disease

Sites in Ogden +19 more locations

Sponsor: Sanofi

Sex: All·Age: 18 - 75

Code: NCT06958536·Phase 2·Recruiting·Listed May 2025

Apply to this trial

Abbott DBS Post-Market Study of Outcomes for Indications Over Time

for Movement Disorders

Sites in Salt Lake City +7 more locations

Sponsor: Abbott Medical Devices

Sex: All·Age: All ages

Code: NCT04071847·Recruiting·Listed Aug 2019

Apply to this trial

EFS of the CardioMech MVRS

for Mitral Regurgitation

Sites in Murray +9 more locations

Sponsor: CardioMech AS

Sex: All·Age: 18+

Code: NCT04820764·Recruiting·Listed Mar 2021

Apply to this trial

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

for Head and Neck Carcinoma

Sites in Salt Lake City +13 more locations

Sponsor: VM Oncology, LLC

Sex: All·Age: 18 - 80

Code: NCT03556228·Phase 1, Phase 2·Recruiting·Listed Jun 2018

Apply to this trial

Melodi Matrix™ in Breast Reconstruction

for Breast Reconstruction

Sites in Salt Lake City +9 more locations

Sponsor: Melodi Health, Inc.

Sex: Female·Age: 22+

Code: NCT06027996·Recruiting·Listed Sep 2023

Apply to this trial

A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

for Secondary Hyperparathyroidism

Sites in Salt Lake City +4 more locations

Sponsor: Amgen

Sex: All·Age: 0 - 18

Code: NCT03633708·Phase 3·Recruiting·Listed Aug 2018

Apply to this trial

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

for Advanced Systemic Mastocytosis (AdvSM)

Sites in Salt Lake City +8 more locations

Sponsor: Cogent Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT04996875·Phase 2·Recruiting·Listed Aug 2021

Apply to this trial

Terumo Aortic Global Endovascular Registry

for Abdominal Aortic Aneurysm

Sites in Salt Lake City +16 more locations

Sponsor: Vascutek Ltd.

Sex: All·Age: 18+

Code: NCT04246463·Recruiting·Listed Jan 2020

Apply to this trial

A Prospective Sub-Study of the Global Hypophosphatasia Registry

for Hypophosphatasia

Sites in Salt Lake City +11 more locations

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All·Age: All ages

Code: NCT05234567·Recruiting·Listed Feb 2022

Apply to this trial

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

for PIK3CA Mutation

Sites in Salt Lake City +22 more locations

Sponsor: Relay Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05216432·Phase 1·Recruiting·Listed Jan 2022

Apply to this trial

IC-8 Apthera IOL New Enrollment Post Approval Study

for Cataract

Sites in Bountiful +13 more locations

Sponsor: Bausch & Lomb Incorporated

Sex: All·Age: 22+

Code: NCT06060041·Recruiting·Listed Sep 2023

Apply to this trial

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

for Low Risk Myelodysplastic Syndromes

Sites in Salt Lake City +12 more locations

Sponsor: Rigel Pharmaceuticals

Sex: All·Age: 18+

Code: NCT05308264·Phase 1, Phase 2·Recruiting·Listed Apr 2022

Apply to this trial

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

for Colorectal Cancer

Sites in Salt Lake City +19 more locations

Sponsor: Tempus AI

Sex: All·Age: 18+

Code: NCT05234177·Recruiting·Listed Feb 2022

Apply to this trial

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

for Relapsed/Refractory Multiple Myeloma

Sites in Salt Lake City +15 more locations

Sponsor: Caribou Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT05722418·Phase 1·Recruiting·Listed Feb 2023

Apply to this trial

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

for Melanoma Stage IIIB

Sites in Salt Lake City, UT +12 more locations

Sponsor: Philogen S.p.A.

Sex: All·Age: 18+

Code: NCT03567889·Phase 3·Recruiting·Listed Jun 2018

Apply to this trial

A Study of RSLV-132 in Females With Sjögren's Disease

for Primary Sjögren Syndrome

Sites in Salt Lake City +23 more locations

Sponsor: Resolve Therapeutics

Sex: Female·Age: 18 - 75

Code: NCT06440525·Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy

for Congenital Myotonic Dystrophy

Sites in Salt Lake City +7 more locations

Sponsor: AMO Pharma Limited

Sex: All·Age: 6 - 45

Code: NCT05004129·Phase 2, Phase 3·Recruiting·Listed Aug 2021

Apply to this trial

US National OCS Liver Perfusion (OLP) Registry

for Liver Transplant

Sites in Salt Lake City +21 more locations

Sponsor: TransMedics

Sex: All·Age: All ages

Code: NCT05940857·Recruiting·Listed Jul 2023

Apply to this trial

A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors

for Low-grade Glioma

Sites in Salt Lake City +11 more locations

Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All·Age: 6 Months - 25

Code: NCT04775485·Phase 2·Recruiting·Listed Mar 2021

Apply to this trial

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

for Relapsed Multiple Myeloma

Sites in Salt Lake City +11 more locations

Sponsor: Opna Bio LLC

Sex: All·Age: 18+

Code: NCT06433947·Phase 1·Recruiting·Listed May 2024

Apply to this trial

Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

for Polycythemia Vera

Drug: Givinostat

Sites in Salt Lake City +13 more locations

Sponsor: Italfarmaco

Sex: All·Age: 18+

Code: NCT06093672·Phase 3·Recruiting·Listed Oct 2023

Apply to this trial

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

for Chronic Lymphocytic Leukemia (CLL)

Sites in Salt Lake City +6 more locations

Sponsor: Nurix Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT04830137·Phase 1·Recruiting·Listed Apr 2021

Apply to this trial

Study With Phage for CF Subjects With Pseudomonas Lung Infection

for Chronic Pseudomonas Aeruginosa Infection

Sites in Salt Lake City +13 more locations

Sponsor: BiomX Ltd

Sex: All·Age: 18+

Code: NCT06998043·Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

for Diabetic Foot Ulcer

Sites in Salt Lake City +9 more locations

Sponsor: Energenesis Biomedical Co., Ltd.

Sex: All·Age: 18+

Code: NCT05930210·Phase 3·Recruiting·Listed Jul 2023

Apply to this trial

InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS

for Respiratory Distress Syndrome (Neonatal)

Sites in Provo +9 more locations

Sponsor: ONY

Sex: All·Age: 29 Weeks - 36 Weeks

Code: NCT05960929·Phase 3·Recruiting·Listed Jul 2023

Apply to this trial

A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy

for Obesity

Sites in Salt Lake City +1 more location

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT07654972·Phase 1·Recruiting·Listed Jun 2026

Apply to this trial

Safety, Tolerability, and PK of AH-008 Following Single Ascending Dose in Healthy Subjects

for Chemotherapy-induced Peripheral Neuropathy (CIPN)

1 location in Salt Lake City

Sponsor: AnHorn Medicines Co. Ltd.

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT07697560·Phase 1·Recruiting·Listed Jul 2026

Apply to this trial

Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients

for Migraine

Sites in Salt Lake City +5 more locations

Sponsor: Aspeya, Inc.

Sex: All·Age: 18 - 65

Code: NCT07646613·Phase 2·Recruiting·Listed Jun 2026

Apply to this trial

A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating Women

for Healthy

Drug: Nipocalimab

1 location in Salt Lake City

Sponsor: Janssen Research & Development, LLC

Sex: Female·Age: 18+·Accepts healthy volunteers

Code: NCT07669077·Phase 1·Recruiting·Listed Jun 2026

Apply to this trial

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

for Colorectal Cancer

Sites in West Valley City +11 more locations

Sponsor: Verastem, Inc.

Sex: All·Age: 18+

Code: NCT07659795·Phase 2·Recruiting·Listed Jun 2026

Apply to this trial

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

for Malignant Neoplasm

Sites in Salt Lake City +11 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 1 Month - 17

Code: NCT07630974·Phase 1, Phase 2·Recruiting·Listed Jun 2026

Apply to this trial

A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

for HIV-1-infection

Sites in Salt Lake City +39 more locations

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT07645287·Phase 2·Recruiting·Listed Jun 2026

Apply to this trial

A Study to Evaluate Ibuprofen (IBU) 62.5 mg and Acetaminophen (APAP) 125 mg/5 ml in an Oral Liquid Suspension Fixed-Dose Combination Product in Children Aged 6 to 11 Years

for Pain

1 location in Salt Lake City

Sponsor: HALEON

Sex: All·Age: 6 - 11·Accepts healthy volunteers

Code: NCT07632274·Phase 1·Recruiting·Listed Jun 2026

Apply to this trial

Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a New Formulation of Inclisiran Containing Polysorbate 80 Compared to the Currently Marketed Formulation

for Inclisiran Formulation

Drug: Inclisiran

Sites in Salt Lake City +2 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 60·Accepts healthy volunteers

Code: NCT07626281·Phase 1·Recruiting·Listed Jun 2026

Apply to this trial

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

for Type 1 Diabetes (T1D)

Sites in Sandy City +5 more locations

Sponsor: DreaMed Diabetes

Sex: All·Age: 18 - 80

Code: NCT07599982·Recruiting·Listed May 2026

Apply to this trial

A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)

for Alopecia Areata

Drug: LY4005130

Sites in South Jordan +8 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 50

Code: NCT07533006·Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

A Phase 1, First-in-human Study of VX-433

for Narcolepsy Type 1 (NT1)

1 location in Salt Lake City

Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All·Age: 18 - 55·Accepts healthy volunteers

Code: NCT07584434·Phase 1·Recruiting·Listed May 2026

Apply to this trial

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

for Myotonic Dystrophy Type 1 (DM1)

Sites in Salt Lake City +9 more locations

Sponsor: Dyne Therapeutics

Sex: All·Age: 16+

Code: NCT07486934·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

for Solid Tumor

Sites in West Valley City +2 more locations

Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT07517198·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

for Atopic Dermatitis (AD)

Sites in South Jordan +4 more locations

Sponsor: Arcutis Biotherapeutics, Inc.

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT07453602·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial